Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-15 Purchase | 2025-12-16 09:30 am | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 11,665 | $4.12 | $48,060 | 1,628,000 (Direct) | View |
| 2025-11-05 Purchase | 2025-11-06 07:30 am | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 500,000 | $2.2 | $1,100,000 | 788,335 (Direct) | View |
| 2025-05-16 Purchase | 2025-05-20 6:03 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 200,000 | $0.48604 | $97,208 | 288,335 (Direct) | View |
| 2024-09-09 Purchase | 2024-09-11 5:46 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 53,432 | $2.8017 | $149,701 | 88,335 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 6:28 pm | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 32,675 | $3.8475 | $125,717 | 34,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-12 Option Award | 2025-12-16 09:30 am | 2026-03-12 2035-12-12 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 828,000 | $0 | 1,628,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 7:29 pm | 2025-09-26 2035-06-26 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:24 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 54,624 | $0 | 218,804 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 82,090 | $0 | 82,090 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:09 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 317,643 | $0 | 512,560 (Direct) | View |
| 2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO | 200,000 | $0 | 0 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:34 pm | 2023-03-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 194,917 | $0 | 194,917 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:42 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 495,211 | $0 | 722,729 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:30 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer | 227,518 | $0 | 227,518 (Direct) | View |